Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage
Pf. Marx et al., Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage, J BIOL CHEM, 275(17), 2000, pp. 12410-12415
Thrombin-activable fibrinolysis inhibitor (TAFI) is present in the circulat
ion as an inactive zymogen. Thrombin converts TAFI to a carboxypeptidase B-
like enzyme (TAFIa) by cleaving at Arg(92) in a process accelerated by the
cofactor, thrombomodulin. TAFIa attenuates fibrinolysis. TAFIa can be inact
ivated by both proteolysis by thrombin and spontaneous temperature-dependen
t loss of activity. The identity of the thrombin cleavage site responsible
for loss of TAFIa activity was suggested to be Arg(330), but site-directed
mutagenesis of this residue did not prevent inactivation of TAFIa by thromb
in, In this study we followed TAFI activation and TAFIa inactivation by thr
ombin/thrombomodulin in time and characterized the cleavage pattern of TAFI
using matrix-assisted laser desorption ionization mass spectrometry, Mass
matching of the fragments revealed that TAFIa was cleaved at Ar-302. Studie
s of a mutant R302Q-TAFI confirmed identification of this thrombin cleavage
site and, furthermore, suggested that inactivation of TAFIa is based on it
s conformational instability rather than proteolytic cleavage at Arg(302).